ILLUMINA, INC.
Close on Oct 19, 2026
- Market cap
- $40.19B
- P/E (TTM)
- 48.8
- Dividend yield
- –
Earnings
Next report expected Oct 29, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 28, 2026 | Jul 30, 2026 | After market close | $1.16B | $1.35 | $1.31 |
| Q1 FY2026 Ended Mar 29, 2026 | Apr 30, 2026 | After market close | $1.09B | $0.87 | $1.15 |
| Q4 FY2025 Ended Dec 28, 2025 | Jan 13, 2026 | Before market open | $1.16B | $2.14 | $1.27 |
| Q3 FY2025 Ended Sep 28, 2025 | Oct 30, 2025 | After market close | $1.08B | $0.98 | $1.34 |
| Q2 FY2025 Ended Jun 29, 2025 | Jul 31, 2025 | After market close | $1.06B | $1.49 | $1.19 |
| Q1 FY2025 Ended Mar 30, 2025 | May 8, 2025 | After market close | $1.04B | $0.82 | – |
| Q4 FY2024 Ended Dec 29, 2024 | Jan 14, 2025 | Before market open | $1.10B | $0.77 | $0.91 |
| Q3 FY2024 Ended Sep 29, 2024 | Nov 4, 2024 | After market close | $1.08B | $4.42 | $1.14 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 2, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 9, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Jul 30, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Non-GAAP diluted EPSnon-GAAP | fiscal year 2026 | $5.30 to $5.40 | Raised |
| Non-GAAP operating marginnon-GAAP | fiscal year 2026 | 23.4% to 23.6% | Maintained |
| ROW organic revenue growthnon-GAAP | fiscal year 2026 | 5% growth | New |
| Total revenue | fiscal year 2026 | $4.60B to $4.64B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Illumina filed with the SEC
NOTICE OF PENDENCY OF THE ACTION, PROPOSED DISMISSAL
Other events · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
Results of operations · Other events · EX-99.1 to Form 8-K
Illumina Announces Changes to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
Results of operations · EX-99.1 to Form 8-K
Illumina completes acquisition of SomaLogic
Acquisition or disposition completed · Other events · EX-99.1 to Form 8-K
Illumina Announces Preliminary Unaudited Financial Results
Results of operations · EX-99.1 to Form 8-K
Illumina Appoints Dr. Eric Green as Chief Medical Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
Results of operations · EX-99.1 to Form 8-K
Illumina to acquire SomaLogic, accelerating its proteomics
Material agreement · Other events · EX-99.1 to Form 8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025
Results of operations · EX-99.1 to Form 8-K
Illumina Board of Directors Elects Dr. Scott Gottlieb Chair,
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Illumina addresses recent developments in China
Regulation FD disclosure · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024
Results of operations · EX-99.1 to Form 8-K
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024
Results of operations · EX-99.1 to Form 8-K
Illumina completes the divestiture of GRAIL
Material agreement · Acquisition or disposition completed · Other events · EX-99.1 to Form 8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
Results of operations · EX-99.1 to Form 8-K
For release April 9, 2024
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023
Results of operations · EX-99.1 to Form 8-K
Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023
Results of operations · EX-99.1 to Form 8-K
Illumina Announces Preliminary Results of Annual Meeting
Other events · EX-99.1 to Form 8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2023;
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022
Results of operations · EX-99.1 to Form 8-K
Francis A. deSouza; Illumina,Inc. - CEO & Director
Results of operations · EX-99.1 to Form 8-K
Preliminary Results of Operations - Non-GAAP
Results of operations · EX-99.2 to Form 8-K
Reconciliation of Non-GAAP Financial Guidance
Results of operations · EX-99.3 to Form 8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022
Results of operations · EX-99.1 to Form 8-K
Illumina Intends to Appeal European Commission’s Decision in GRAIL Deal
Other events · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
Results of operations · EX-99.1 to Form 8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
Preliminary Results of Operations - Non-GAAP
Results of operations · EX-99.2 to Form 8-K
Reconciliation of Non-GAAP Financial Guidance
Results of operations · EX-99.3 to Form 8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021
Results of operations · EX-99.1 to Form 8-K